Literature DB >> 33633615

Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies.

Jun-Fang Zhang1, Xi-Xi Wang1,2, Ya Feng1, Robert Fekete3, Joseph Jankovic4, Yun-Cheng Wu1.   

Abstract

Impulse control disorders (ICDs) in Parkinson's disease (PD) are aberrant behavior such as pathological gambling, hypersexuality, binge eating, and compulsive buying, which typically occur as a result of dopaminergic therapy. Numerous studies have focused on the broad spectrum of ICDs-related behaviors and their tremendous impact on patients and their family members. Recent advances have improved our understanding of ICDs. In this review, we discuss the epidemiology, pathogenesis and treatment of ICDs in the setting of PD.
Copyright © 2021 Zhang, Wang, Feng, Fekete, Jankovic and Wu.

Entities:  

Keywords:  Parkinson's disease; binge eating; compulsive buying; dopaminergic drugs; hypersexuality; impulse control disorders; pathological gambling

Year:  2021        PMID: 33633615      PMCID: PMC7900512          DOI: 10.3389/fpsyt.2021.635494

Source DB:  PubMed          Journal:  Front Psychiatry        ISSN: 1664-0640            Impact factor:   4.157


  137 in total

Review 1.  The orbitofrontal cortex and reward.

Authors:  E T Rolls
Journal:  Cereb Cortex       Date:  2000-03       Impact factor: 5.357

2.  Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation.

Authors:  Claire Ardouin; Valerie Voon; Yulia Worbe; Nehman Abouazar; Virginie Czernecki; Hassan Hosseini; Antoine Pelissolo; Elena Moro; Eugénie Lhommée; Anthony E Lang; Yves Agid; Alim-Louis Benabid; Pierre Pollak; Luc Mallet; Paul Krack
Journal:  Mov Disord       Date:  2006-11       Impact factor: 10.338

3.  Levodopa infusion improves impulsivity and dopamine dysregulation syndrome in Parkinson's disease.

Authors:  María José Catalán; Eduardo de Pablo-Fernández; Clara Villanueva; Servando Fernández-Diez; Teresa Lapeña-Montero; Rocío García-Ramos; Eva López-Valdés
Journal:  Mov Disord       Date:  2013-10-10       Impact factor: 10.338

4.  Impulsive-compulsive behaviors in parkin-associated Parkinson disease.

Authors:  Francesca Morgante; Alfonso Fasano; Monia Ginevrino; Simona Petrucci; Lucia Ricciardi; Francesco Bove; Chiara Criscuolo; Marcello Moccia; Anna De Rosa; Chiara Sorbera; Anna Rita Bentivoglio; Paolo Barone; Giuseppe De Michele; Maria Teresa Pellecchia; Enza Maria Valente
Journal:  Neurology       Date:  2016-09-02       Impact factor: 9.910

5.  Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.

Authors:  Daniel Weintraub; Mandy Sohr; Marc N Potenza; Andrew D Siderowf; Mark Stacy; Valerie Voon; Jacqueline Whetteckey; Glen R Wunderlich; Anthony E Lang
Journal:  Ann Neurol       Date:  2010-12       Impact factor: 10.422

Review 6.  Epidemiology of Parkinson's disease.

Authors:  Lonneke M L de Lau; Monique M B Breteler
Journal:  Lancet Neurol       Date:  2006-06       Impact factor: 44.182

7.  Compulsive eating and weight gain related to dopamine agonist use.

Authors:  Melissa J Nirenberg; Cheryl Waters
Journal:  Mov Disord       Date:  2006-04       Impact factor: 10.338

8.  Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease.

Authors:  Kara M Smith; Sharon X Xie; Daniel Weintraub
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-11-03       Impact factor: 10.154

Review 9.  Getting a grip on problem gambling: what can neuroscience tell us?

Authors:  Anna E Goudriaan; Murat Yücel; Ruth J van Holst
Journal:  Front Behav Neurosci       Date:  2014-05-20       Impact factor: 3.558

10.  Impulse control disorder related behaviours during long-term rotigotine treatment: a post hoc analysis.

Authors:  A Antonini; K R Chaudhuri; B Boroojerdi; M Asgharnejad; L Bauer; F Grieger; D Weintraub
Journal:  Eur J Neurol       Date:  2016-07-18       Impact factor: 6.089

View more
  1 in total

1.  The protective role of cigarette smoking against Parkinson's disease via moderation of the interaction between iron deposition in the nigrostriatal pathway and clinical symptoms.

Authors:  Quanquan Gu; Xiaocao Liu; Qingze Zeng; Xiaojun Guan; Cheng Zhou; Tao Guo; Baorong Zhang; Minming Zhang
Journal:  Quant Imaging Med Surg       Date:  2022-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.